[1]
P. T. Gozzi, F. G. Bueno, P. M. da R. Zimmermann, e L. B. Junior, “ELABORATION OF GUIDELINE FOR MONITORING IN RELATIVE BIOAVAILABILITY / PHARMACEUTICAL BIOEQUIVALENCE STUDY BY THE SPONSOR”, Arq. Ciênc. Saúde Unipar, vol. 26, nº 3, set. 2022.